2.39
Schlusskurs vom Vortag:
$2.35
Offen:
$2.31
24-Stunden-Volumen:
12,501
Relative Volume:
0.02
Marktkapitalisierung:
$10.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-128.28M
KGV:
-0.039
EPS:
-61.2898
Netto-Cashflow:
$-5.26M
1W Leistung:
+0.84%
1M Leistung:
-6.27%
6M Leistung:
-21.59%
1J Leistung:
+0.00%
Lunai Bioworks Inc Stock (LNAI) Company Profile
Firmenname
Lunai Bioworks Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare LNAI vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LNAI
Lunai Bioworks Inc
|
2.39 | 9.97M | 0 | -128.28M | -5.26M | -61.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lunai Bioworks Inc Aktie (LNAI) Neueste Nachrichten
Lunai (LNAI) Earnings Data Review: The Company Reports Its Latest Available Figures in the Latest Reading; Closing Response: The Market Price Declines 3.78% in the Latest ReadingNet Income Trends - vinanet.vn
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lunai Bioworks (LNAI) Slips 1.44% to $2.40 as Biotech Traders Eye Key $2.28 SupportTake Profit Levels - vinanet.vn
Lunai Bioworks (LNAI) Slips 1.18% as Shares Test Key Support Near $2.39Block Trade Flow - dars.gov.et
Lunai Bioworks signs collaboration with BrainStorm Therapeutics - Investing.com
Lunai Bioworks files amended complaint alleging naked short selling - Investing.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics By Investing.com - Investing.com UK
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - 富途牛牛
Lunai Bioworks files amended complaint alleging naked short selling By Investing.com - Investing.com India
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - Yahoo Finance
LNAI Q2 2026 Earnings: Biotech Posts $0.08 Per-Share Loss; Stock Retreats 3.96%Upward Estimate Revision - vinanet.vn
LNAI Q2 2026 Earnings: Reported Loss of -$0.08 Per Share as Stock Climbs 5.45%Analyst Earnings Estimate - vinanet.vn
Lunai Bioworks (LNAI) Declines 4.27%, Testing Key Support Near $1.92Unusual Put Volume - dars.gov.et
LNAI Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrower Loss; Stock Falls 5.21%Retail Earnings Report - vinanet.vn
LNAI: Lunai Bioworks Inc.Financial Overview - Zacks Investment Research
Lunai Bioworks Holds Steady at $2.24: Consolidation Phase Amid Key SupportVolume Rate Change - vinanet.vn
LNAI|Lunai Bioworks Ord Shs|Price:2.240|Chg%:-0.090 - TradingKey
Lunai Bioworks Ord Shs (LNAI) Institutional Confidence - TradingKey
Lunai Bioworks Inc. Revenue Breakdown – NASDAQ:LNAI - TradingView
Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lunai Bioworks(LNAI) Stock Options Chain | Quotes & News - Moomoo
Lunai Bioworks Inc. (LNAI) investor group discloses 9.41% stake in Schedule 13G - Stock Titan
Lunai Bioworks (LNAI) Tests Key Support After 3.4% DeclineIron Condor Alert - vinanet.vn
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Shares SlideEarnings Miss Streak - dars.gov.et
LNAI Q2 2026 Earnings: Biotech Reports Narrowing Loss, Shares Rise 7.1%Debt Analysis Report - dars.gov.et
Lunai Bioworks Q2 2026 Earnings: Loss of $0.08 Per Share as Stock Gains 7.1% on Pipeline Progress - dars.gov.et
RENB SEC FilingsRenovaro 10-K, 10-Q, 8-K Forms - Stock Titan
Lunai Bioworks (LNAI) Slides 9.7%: Key Support Levels in Focus After Sharp DeclineSmart Beta Flow - dars.gov.et
LUNAI BIOWORKS INC (LNAI) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to earnings forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to earnings forward of Lunai Bioworks, Inc. – FWB:2Q5 - TradingView
EBITDA per share of Lunai Bioworks, Inc. – FWB:2Q5 - TradingView
LNAI Should I Buy - Intellectia AI
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Modest Loss, Stock Gains on Pipeline OptimismEarnings Miss Alert - dars.gov.et
Lunai Bioworks (LNAI) Revenue BreakdownMain Composition - Moomoo
Enterprise value to EBIT forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Enterprise value to revenue forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Enterprise value to revenue forward of Lunai Bioworks, Inc. – LS:A42CL6 - TradingView
Price to book forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to book forward of Lunai Bioworks, Inc. – LS:A42CL6 - TradingView
Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session - MSN
Lunai Bioworks Inc. (NASDAQ: LNAI) Share Price, LNAI Stock News, LNAI Share Price & Updates - Kalkine
LNAI Q1 2026 Earnings: Lunai Bioworks Reports Loss While Stock Moves Higher on Pipeline OptimismMargin Expansion Trends - dars.gov.et
Lunai Bioworks Inc. (LNAI) Surges 10% as Bullish Momentum Builds Above Key SupportContinuation Pattern Picks - dars.gov.et
Lunai Bioworks Ord Shs (LNAI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LNAI Q1 2026 Earnings: Pre-Revenue Biotech Posts EPS of -$0.08, Stock Declines 5.5%CFO Commentary Report - po-news-eg.net
Lunai Bioworks Pursues Legal Action Over Alleged Manipulation - TipRanks
Lunai Bioworks (LNAI) Stock Jumps 81% After Nasdaq Compliance News - MEXC
Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit - TradingView
Finanzdaten der Lunai Bioworks Inc-Aktie (LNAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):